# Precision Medicine * **Definition:** An innovative approach to healthcare that customizes medical treatment to the individual characteristics of each patient, taking into account genetic, environmental, and lifestyle factors to optimize therapeutic outcomes while minimizing adverse effects. * **Taxonomy:** Healthcare Topics / Precision Medicine ## News * Selected news on the topic of **Precision Medicine**, for healthcare technology leaders * 17.8K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/28/2025 | [**Global AI in Precision Medicine Market is Expected to Showcase a Significant Growth at a Massive CAGR of ~33y 2032 - DelveInsight**](https://www.globenewswire.com/news-release/2025/05/28/3089834/0/en/Global-AI-in-Precision-Medicine-Market-is-Expected-to-Showcase-a-Significant-Growth-at-a-Massive-CAGR-of-33-by-2032-DelveInsight.html) | [[Globe Newswire]] | | 5/9/2025 | [**Precision Medicine Market Analysis Report 2024-2030: Bristol-Myers Squibb, Illumina ...**](https://finance.yahoo.com/news/precision-medicine-market-analysis-report-131300143.html) | [[Yahoo Finance]] | | 4/18/2025 | [**Leukemia Cells Reprogrammed with Epigenetic Switch**](https://www.insideprecisionmedicine.com/topics/oncology/leukemia-cells-reprogrammed-with-epigenetic-switch/) | [[Inside Precision Medicine]] | | 4/18/2025 | [**Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week**](https://www.prnewswire.com/news-releases/declaration-on-longevity-and-precision-medicine-launched-at-abu-dhabi-global-health-week-302432556.html) | [[PR Newswire]] | | 4/15/2025 | [**Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation**](https://finance.yahoo.com/news/illumina-tempus-partner-drive-future-131500785.html) | [[Yahoo Finance]] | | 3/11/2025 | [**Equipping Healthcare Professionals for the AI-Powered Healthcare Revolution: Lessons ... - Medium**](https://medium.com/@alexglee/equipping-healthcare-professionals-for-the-ai-powered-healthcare-revolution-lessons-from-harvard-e8f83dd3df8b) | [[Medium]] | | 2/21/2025 | [**Roundup: AI and cloud tackle cyber risk and improve workflows - Healthcare IT News**](https://www.healthcareitnews.com/news/roundup-ai-and-cloud-tackle-cyber-risk-and-improve-workflows) | [[Healthcare IT News]] | | 1/31/2025 | [**Deloitte Earns Top Recognition in Healthcare IT for AI, Cloud, and Digital Innovation, Black ...**](https://finance.yahoo.com/news/deloitte-earns-top-recognition-healthcare-194500093.html) | [[Yahoo Finance]] | | 1/6/2025 | [**Asia-Pacific Precision Medicine Software Market Analysis and Forecast 2024-2033**](https://finance.yahoo.com/news/asia-pacific-precision-medicine-software-124400953.html) | [[Yahoo Finance]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Leading the Quantum AI Revolution: AQSolotl Solidifies Milestone Collaboration in Singapore**](https://finance.yahoo.com/news/leading-quantum-ai-revolution-aqsolotl-065800722.html) | [[Yahoo Finance]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/30/2024 | [**Precision Medicine Software Research Analysis Report 2024-2030: Increasing Adoption of Genomic Data Analysis Software Spurs Growth, Integration of Multi-Omics Data Strengthens the Business Case - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241230952002/en/Precision-Medicine-Software-Research-Analysis-Report-2024-2030-Increasing-Adoption-of-Genomic-Data-Analysis-Software-Spurs-Growth-Integration-of-Multi-Omics-Data-Strengthens-the-Business-Case---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/24/2024 | [**Precision Medicine Software Research Analysis Report 2024: Market to Reach $4.4 Billion ...**](https://finance.yahoo.com/news/precision-medicine-software-research-analysis-132900381.html) | [[Yahoo Finance]] | | 12/4/2024 | [**Precision Medicine Market to grow by USD 66.2 Billion (2024-2028), rising chronic disease prevalence driving revenue, with AI redefining the landscape - Technavio**](https://www.prnewswire.com/news-releases/precision-medicine-market-to-grow-by-usd-66-2-billion-2024-2028-rising-chronic-disease-prevalence-driving-revenue-with-ai-redefining-the-landscape---technavio-302320916.html) | [[PR Newswire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.morningstar.com/news/business-wire/20241029349293/precision-medicine-global-thought-leader-dr-howard-mcleod-joins-cofactor-genomics-advisory-board-as-cofactor-brings-oncoprism-test-to-partnered-hospitals) | [[Morningstar]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals) | [[Business Wire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics' Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals**](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 8/12/2024 | [**Big Data and Precision Medicine: Diagnosis and Treatment, Drug Discovery, and Integration of Multiple Omics**](https://www.frontiersin.org/research-topics/66610/big-data-and-precision-medicine-diagnosis-and-treatment-drug-discovery-and-integration-of-multiple-omics/impact) | frontiersin.org | | 7/17/2024 | [**Data Privacy in Healthcare: Balancing Innovation with Patient Security**](https://www.healthcareittoday.com/2024/07/17/data-privacy-in-healthcare-balancing-innovation-with-patient-security/) | [[Healthcare IT Today]] | | 7/11/2024 | [**Precision Medicine Software Market 2031 with CAGR of 11.7% - WhaTech**](https://www.whatech.com/og/markets-research/it/855386-precision-medicine-software-market-2031-with-cagr-of-11-7) | whatech.com | | 7/3/2024 | [**The Power of Precision Medicine in Revolutionizing Healthcare**](https://www.healthcaretechoutlook.com/news/the-power-of-precision-medicine-in-revolutionizing-healthcare-nid-4193.html) | healthcaretechoutlook.com | | 6/4/2024 | [**Unlocking the Power of Patient Data: A Catalyst for Precision Medicine**](https://www.insideprecisionmedicine.com/topics/precision-medicine/unlocking-the-power-of-patient-data-a-catalyst-for-precision-medicine/) | [[Inside Precision Medicine]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **BostonGene**: Specializes in AI-driven molecular and immune profiling solutions to enhance access to precision medicine. - **ImpriMed**: A functional precision medicine company expanding into human oncology, focusing on drug response predictions. - **Promise Bio**: A startup focused on precision medicine for immune-mediated diseases using AI and epiproteomics. - **Mercy**: A healthcare organization that hosted the inaugural Precision Medicine Summit, focusing on advancements in personalized healthcare. - **Foundation Medicine, Inc.**: Offers genomic profiling and clinical decision support tools. - **Scipher Medicine**: Integrates transcriptomic data for personalized treatment in immunology. - **Tempus AI, Inc.**: Focused on AI-enabled precision medicine solutions, leveraging a multimodal data library to enhance personalized patient care. - **BePRECISE Consortium**: A group of 23 global experts developing guidelines to enhance reporting in precision medicine research. - **Illumina**: A leading company in genomic technologies, focusing on next-generation sequencing to enhance precision medicine. - **Biocompare**: A division of CompareNetworks Inc. that launched a documentary series to educate on technological advances in precision medicine. - **Fabric Genomics, Inc.**: Focuses on genomic data analysis and personalized treatment plans. - **Tempus**: A technology company that integrates AI and multimodal data to support precision medicine and molecular testing. - **2bprecise, LLC**: A company specializing in precision medicine software solutions. - **Oxford Nanopore Technologies**: Collaborating with Singapore's National Precision Medicine program to sequence 10,000 genomes. - **Pfizer**: A major pharmaceutical player focusing on personalized treatment approaches. - **Syapse**: Provides solutions for genomics analysis and patient engagement. - **Ataraxis AI**: A precision medicine company developing AI-powered diagnostic tests to enhance patient outcome predictions. - **Caris Life Sciences**: An AI TechBio company specializing in precision medicine through molecular profiling. - **CareDx, Inc.**: A precision medicine company focused on transplant patients, known for its innovations in AI-enabled rejection risk prediction models. ### Partnerships and Collaborations - **Precision Health Research, Singapore (PRECISE) and IHCC**: Collaborated on a conference to enhance global precision medicine through large-scale genomics. - **Illumina and Tempus**: Collaborating to enhance clinical adoption of next-generation sequencing and integrate AI-powered precision medicine into standard care. - **Singapore National Precision Medicine Program and Oxford Nanopore**: Working together to sequence 10,000 genomes to understand local genetic diversity. - **UAE's Declaration on Longevity and Precision Medicine**: A collaborative effort to advance precision medicine and longevity science globally. - **Caris Precision Oncology Alliance**: A collaboration of 96 cancer centers and institutions aimed at advancing precision oncology. - **OMNY Health and Scipher Medicine**: Collaborating to integrate transcriptomic data with EHRs to enhance precision medicine for immunology, particularly for rheumatoid arthritis. - **NHLBI and Westat**: Partnership to establish the AI Coordinating Center for coordinating research initiatives in precision medicine. - **Epic and GeneDx**: Integrating rapid whole genome sequencing technology into Epic's EHR system. - **BIOMAKERS and TOPAZIUM**: Collaborating to utilize AI and DNA sequencing data to enhance immunotherapy efficacy for non-small cell lung cancer. - **Sonrai Analytics and Massachusetts General Hospital**: Collaborating to implement cloud-based AI technology for enhanced data integration and analysis in therapeutic development. - **AstraZeneca and Scorpion Therapeutics**: Collaborated to develop precision medicines targeting difficult cancer proteins. - **Cleveland Clinic and IBM**: Initiated a global AI collaboration to advance medical research in genomics and precision medicine. - **BioAI and Genomic Testing Cooperative (GTC)**: Collaborating to enhance biomarker discovery and diagnostics using AI, leveraging GTC's imaging data for product development. - **TetraScience and Databricks**: Collaborating to utilize AI for enhancing drug development and clinical trial outcomes. - **GE HealthCare and UC San Diego**: Collaborating to explore advanced MRI protocols for female-specific pelvic diseases. - **Software and Pharmaceutical Companies**: Increasing collaboration to combine advanced technology with pharmaceutical expertise to improve drug development and patient care outcomes. - **Caris Life Sciences and Ontada**: A strategic collaboration to combine genomic and clinical data to enhance cancer care and develop next-generation therapies. - **Memorial Sloan Kettering Cancer Center and Amazon Web Services**: A partnership aimed at utilizing AI to unlock data and advance oncology care through extensive cancer research data. - **Bumrungrad International Hospital and Golden Helix**: A partnership to enhance genomics initiatives for cancer and hereditary disease diagnostics. - **Texas A&M Health and BurstIQ**: Utilizing the LifeGraph platform to enhance clinical research through improved data management and patient privacy. ### Innovations, Trends, and Initiatives - **Precision Medicine Summit 2025**: An event focusing on the future of precision medicine, addressing challenges like data integration, privacy concerns, and the need for improved provider education. - **Precision Medicine Software Market**: Projected to reach USD 1.85 billion in 2023, driven by advancements in AI technology. - **Personalized Treatment Pathways**: Emerging technologies are enabling tailored treatment strategies based on genetic data. - **AI and Machine Learning Integration**: Enhances data analysis and personalized treatment options in precision medicine. - **AI in Precision Medicine**: Utilizing AI algorithms for predictive analytics and personalized treatment plans based on genetic, lifestyle, and environmental factors. - **Whole Genome and Exome Sequencing**: The market is projected to grow significantly, enhancing personalized medicine through genetic insights. - **Generative AI**: Revolutionizing precision medicine by improving disease diagnosis, personalizing treatment plans, and speeding up drug discovery. - **BePRECISE Guidelines**: A new international guideline to improve reporting in precision medicine research, emphasizing health equity. - **Healthtech Innovation Hub**: Upcoming event showcasing advancements in health technology, including precision medicine. - **Pharmacogenomics Testing**: Tailors medication choices based on genetic makeup, enhancing safety and efficacy in treatment. - **Market Growth**: The global precision medicine market is projected to grow from $89.9 billion in 2023 to $161.1 billion by 2030, driven by technological advancements. - **Next-Generation Sequencing**: Facilitates the identification of actionable biomarkers, particularly in oncology. - **AI and Machine Learning**: Transforming healthcare through improved diagnostic accuracy and personalized treatment plans. - **Liquid Biopsy Technology**: Revolutionizing cancer treatment by providing real-time insights into cancer progression, enabling personalized interventions. - **Cancer Informatics**: Growing focus on managing complex data related to cancer treatment and outcomes. - **Digital Pathology**: Accelerating adoption of digital pathology to enable quicker delivery of biomarker results. - **Precision Insurance Plans (PIPs)**: Emerging insurance models tailored to individual health risks using advanced data analytics. ### Challenges and Concerns - **High Costs of Precision Medicine**: Challenges in affordability and accessibility for patients and healthcare systems. - **Need for Extensive Training**: Healthcare professionals require significant training to effectively utilize precision medicine tools. - **Access Disparities**: Ensuring equitable access to precision medicine tools and treatments across different demographics and regions remains a significant concern. - **Data Privacy and Compliance**: Challenges related to patient privacy, regulatory compliance (e.g., HIPAA), and cybersecurity threats hinder the widespread adoption of precision medicine technologies. - **Data Privacy**: Concerns regarding the security of sensitive genomic information as AI and precision medicine become more prevalent. - **Regulatory Compliance**: The need for adherence to standards to protect patient information while implementing precision medicine solutions. - **Access to Specialized Care**: Challenges in ensuring access to precision medicine, particularly in smaller cities and rural areas. - **Data Privacy and Security**: Concerns regarding the handling of sensitive health data could hinder the growth of precision medicine. - **High Implementation Costs**: Hinders widespread adoption of precision medicine software, especially in smaller healthcare institutions. - **Regulatory Hurdles**: Navigating regulatory frameworks for new precision medicine technologies can be complex. - **Cost of Genomic Testing**: High costs associated with genomic testing and the need for affordable solutions to enhance access to precision medicine. - **Underutilization of Molecular Profiling**: Despite advancements, molecular profiling remains underutilized in clinical settings outside oncology. - **Underrepresentation in Genomic Research**: African populations are underrepresented in genomic studies, hindering the development of effective precision medicine programs. - **Interoperability Issues**: Fragmentation in the healthcare ecosystem due to interoperability challenges, hindering effective data sharing and impacting precision medicine. - **Data Fragmentation**: Hinders advancements in patient care and clinical research, complicating early disease detection. - **Data Privacy Concerns**: The need for ethical considerations in monetizing patient data and ensuring patient consent. ## Related Topics [[Precision Medicine Software]]; [[Personalized Medicine]]; [[AI in Precision Medicine]]; [[Hyper-Personalized Medicine]]; [[Precision Oncology]]